QID 379457

Date Published: 2024-03-18

QID 379457: IBM Aspera Faspex Hypertext Transfer Protocol (HTTP) Header Injection Vulnerability (6618959)

Faspex is a centralized transfer solution that enables users to exchange files with each other using an email-like workflow.

CVE-2022-22399: IBM Aspera Faspex 5 is vulnerable to HTTP header injection, caused by improper validation of input by the HOST headers. This could allow an attacker to conduct various attacks against the vulnerable system, including cross-site scripting, cache poisoning or session hijacking.

Affected platform: Linux
Affected Versions: IBM Aspera Faspex 5.0.0
IBM Aspera Faspex 5.0.1

QID Detection Logic (Authenticated):
(Linux)This QID uses package based query in case of Linux.
QID Detection Logic (Unauthenticated):
This QID send a GET request to aspera/faspex page to check the vulnerable version.

Successful exploitation of this vulnerability could allow an attacker to conduct various attacks against the vulnerable system, including cross-site scripting, cache poisoning or session hijacking.

CVSS V3 rated as Medium - 5.4 severity.

CVSS V2 rated as High - 6.4 severity.

Solution

Vendor has released updated versions to fix these vulnerabilities. Please refer IBM Aspera Faspex Security Advisory (CVE-2022-22399)

Vendor References

6618959 - www.ibm.com/support/pages/security-bulletin-ibm-aspera-faspex-500501-affected-vulnerability-cve-2022-22399

CVEs related to QID 379457

CVE-2022-22399 |

Software Advisories

Advisory ID	Software	Component	Link
6618959			www.ibm.com/support/pages/security-bulletin-ibm-aspera-faspex-500501-affected-vulnerability-cve-2022-22399

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].